Postnatal lethality and abnormal development of foregut and spleen in Ndrg4 mutant mice

Biochemical and Biophysical Research Communications
Xianghu QuH Scott Baldwin

Abstract

NDRG4 is a member of the NDRG family (N-myc downstream-regulated gene), which is highly expressed in brain and heart. Previous studies showed that Ndrg1-deficient mice exhibited a progressive demyelinating disorder of peripheral nerves and Ndrg4-deficient mice had spatial learning deficits and vulnerabilities to cerebral ischemia. Here, we report generation of Ndrg4 mutant alleles that exhibit several development defects different from those previously reported. Our homozygous mice showed growth retardation and postnatal lethality. Spleen and thymuses of Ndrg4(-/-) mice are considerably reduced in size from 3 weeks of age. Histological analysis revealed abnormal hyperkeratosis in the squamous foregut and abnormal loss of erythrocytes in the spleen of Ndrg4(-/-) mice. In addition, we observed an abnormal hind limb clasping phenotype upon tail suspension suggesting neurological abnormalities. Consistent to these abnormalities, Ndrg4 is expressed in smooth muscle cells of the stomach, macrophages of the spleen and neurons. Availability of the conditional allele for Ndrg4 should facilitate further detailed analyses of the potential roles of Ndrg4 in gut development, nervous system and immune system.

References

Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·M LaksoH Westphal
Jun 1, 2000·American Journal of Human Genetics·L KalaydjievaP K Thomas
Dec 6, 2000·Genesis : the Journal of Genetics and Development·F W FarleyS M Dymecki
May 21, 2003·European Journal of Biochemistry·Shinichi NishimotoToshi Komurasaki
Apr 15, 2004·Molecular and Cellular Biology·Tomohiko OkudaToshiyuki Miyata
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sophia H L GeorgeAndras Nagy
Nov 14, 2007·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Tomohiko OkudaToshiyuki Miyata
Mar 13, 2010·Development·Xianghu QuScott Baldwin
Jul 30, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Veerle MelotteManon van Engeland
Feb 10, 2011·Neurobiology of Disease·Rosalind H M KingLuba Kalaydjieva
Jun 4, 2011·The Journal of Biological Chemistry·Hitomi YamamotoToshiyuki Miyata
Jul 24, 2012·Developmental Biology·Huang ZhuXizhi Guo
Feb 27, 2014·Nature Communications·Shingo NakahataKazuhiro Morishita

❮ Previous
Next ❯

Citations

May 20, 2017·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·N VaesV Melotte
Dec 20, 2017·Oncotarget·Mingfei ZhuBo Zuo
Apr 11, 2020·Computational and Mathematical Methods in Medicine·Yanhui WangDazhi Meng
Jul 20, 2021·Frontiers in Genetics·Eliah G OverbeyYvonne Drechsler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

© 2022 Meta ULC. All rights reserved